• Regulatory NewsRegulatory News

    EMA’s CHMP Recommends Approval for Five New Medicines, Four New Biosimilars

    The European Medicines Agency (EMA) met earlier this week and signed off on five new medicines, including one new advanced therapy, as well as four biosimilars and one generic drug. The advanced therapy CHMP recommended is Germany-based Co Don Ag’s Spherox (spheroids of human autologous matrix-associated chondrocytes), which is intended to treat adults who have a type of symptomatic articular cartilage defects in the knee. The four other new medicines were: Dom...